112 related articles for article (PubMed ID: 23833712)
1. A Single Gradient Stability-Indicating Reversed-Phase LC Method for the Estimation of Impurities in Omeprazole and Domperidone Capsules.
Seshadri RK; Raghavaraju TV; Chakravarthy IE
Sci Pharm; 2013; 81(2):437-8. PubMed ID: 23833712
[TBL] [Abstract][Full Text] [Related]
2. Complexity in estimation of esomeprazole and its related impurities' stability in various stress conditions in low-dose aspirin and esomeprazole magnesium capsules.
Reddy PS; Hotha KK; Sait S
Sci Pharm; 2013; 81(2):475-92. PubMed ID: 23833714
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating LC-UV method for the determination of eszopiclone and degradation impurities in tablet dosage form.
Shaikh K; Patil A; Gite S
J Chromatogr Sci; 2014 Apr; 52(4):293-7. PubMed ID: 23552846
[TBL] [Abstract][Full Text] [Related]
4. Forced degradation study and characterization of main impurities of ibuprofen soft gelatin capsules by LC-MS-QTOF.
Farias FF; Martins VAP; Dörr FA; Trujillo LM; Pinto E
Pharmazie; 2021 Apr; 76(4):138-144. PubMed ID: 33849697
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.
Raju TV; Seshadri RK; Arutla S; Mohan TS; Rao IM; Nittala SR
Sci Pharm; 2013; 81(1):123-38. PubMed ID: 23641333
[TBL] [Abstract][Full Text] [Related]
6. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
[TBL] [Abstract][Full Text] [Related]
7. Stability Indicating Liquid Chromatographic Method for Simultaneous Determination of Aspirin and Omeprazole.
Patel VB; Patel AD; Shah DA
Curr Drug Discov Technol; 2018; 15(4):351-360. PubMed ID: 29065836
[TBL] [Abstract][Full Text] [Related]
8. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
9. Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation.
Katakam LNR; Dongala T; Ettaboina SK
Biomed Chromatogr; 2021 May; 35(5):e5062. PubMed ID: 33410554
[TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets.
Shaikh KA; Patil AT
Sci Pharm; 2012; 80(4):879-88. PubMed ID: 23264937
[TBL] [Abstract][Full Text] [Related]
11. Stability of capsules containing omeprazole in enteric coated pellets.
Palummo M; Cingolani A; Dall L; Volonté MG
Boll Chim Farm; 2000; 139(3):124-8. PubMed ID: 10961022
[TBL] [Abstract][Full Text] [Related]
12. A new validated liquid chromatographic method for the determination of loratadine and its impurities.
Ramulu G; Ravindra Kumar Y; Vyas K; Suryanarayana MV; Mukkanti K
Sci Pharm; 2011; 79(2):277-91. PubMed ID: 21773066
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Rosuvastatin and Related Substances in Pharmaceutical Dosage Form.
Trivedi HK; Patel MC
Sci Pharm; 2012; 80(2):393-406. PubMed ID: 22896825
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Halometasone, Fusidic Acid, Methylparaben, and Propylparaben in Topical Pharmaceutical Formulation.
Goswami N; Gupta VR; Jogia HA
Sci Pharm; 2013; 81(2):505-18. PubMed ID: 23833716
[TBL] [Abstract][Full Text] [Related]
15. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.
Mallikarjuna Rao B; Sangaraju S; Srinivasu MK; Madhavan P; Lalitha Devi M; Rajendra Kumar P; Chandrasekhar KB; Arpitha Ch; Satya Balaji T
J Pharm Biomed Anal; 2006 Jun; 41(4):1146-51. PubMed ID: 16563688
[TBL] [Abstract][Full Text] [Related]
17. A validated stability indicating LC method for Nateglinide.
Pathare DB; Jadhav AS; Shingare MS
Drug Dev Ind Pharm; 2007 May; 33(5):551-7. PubMed ID: 17520447
[TBL] [Abstract][Full Text] [Related]
18. Stability-indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation.
Chhalotiya UK; Bhatt KK; Shah DA; Patel JR
Sci Pharm; 2012; 80(2):407-17. PubMed ID: 22896826
[TBL] [Abstract][Full Text] [Related]
19. Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.
Trivedi HK; Patel MC
Sci Pharm; 2012; 80(4):889-902. PubMed ID: 23264938
[TBL] [Abstract][Full Text] [Related]
20. Development of a stability-indicating RP-LC method for the separation of a critical pair of impurities and their degradants in zafirlukast.
Thiyagarajan TK; Abdul Hakeem JA; Baksam V
J Chromatogr Sci; 2012; 50(10):945-52. PubMed ID: 22689905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
